Types of Gene Therapy

First-ever gene therapy for hearing loss gets FDA approval

Gene therapy for a rare type of deafness shows lasting results

Researchers say a gene therapy allowed deaf children and adults as old as 32 to hear for the first time. The benefits have persisted for more than two years for some patients.

· 3d

New Gene Therapy For Rare Hearing Loss Wins FDA Approval—What To Know

· 3d

Regeneron weighs overseas price for Otarmeni, gene therapy for rare type of hearing loss

Genprex Collaborators to Present Positive Preclinical Data on Diabetes Gene Therapy for Type 2 Diabetes at the 2026 American Society of Gene and Cell Therapy Annual …

Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing ...

Forbes

Gene Therapy Could End Lifelong Transfusions For Rare Blood Disorder

A single one-time gene therapy could free patients with α-thalassemia, a rare and debilitating blood disorder, from the burden of lifelong transfusions. A single one-time gene therapy could ...

Medscape

The Gene Therapy Poised to Rewrite Childhood Deafness

Four decades have passed since cochlear implants gave infants born deaf the ability to hear. Now, gene therapy promises to restore natural hearing for those born with a rare form of deafness, and ...

Latus Bio to Present New Data at ASGCT 2026 Supporting Investigational Gene Therapy Approaches for Huntington’s Disease and CLN2 Disease

Latus Bio, Inc. (Latus), a company advancing scalable genetic medicines for broad patient populations, today announced it ...

GEN

Single-Assay Evaluation of AAV Capsid Quality: Novel Digital PCR Approaches Advance Gene Therapy Research and Production

Gene therapy (introducing genetic material into living cells to fix, replace, enhance, or block a faulty gene) is rapidly gaining traction as a strategy for the treatment of genetic diseases ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results